Key facts
Consultation rates for respiratory illness in both primary and secondary care are slowly increasing, but remain at low or baseline levels in all reporting EU/EEA countries.
SARS-CoV-2 remains the main contributor to respiratory virus activity this week, with median test positivity of 11% in primary and secondary care. However, influenza virus activity is increasing, with median test positivity at around 5% in both primary and secondary care.
- SARS-CoV-2 test positivity continues to increase in many countries, both in clinical case definition-based and laboratory-based surveillance systems. Most detections in secondary care are reported among adults aged over 65 years.
- Influenza virus activity remains relatively low overall throughout the EU/EEA. Influenza detections are reported in both primary and secondary care. Since week 37, numbers have been consistently higher than during interepidemic levels, but the epidemic has not yet started. Most detections in secondary care are among adults aged over 65 years. Detected viruses belong to the influenza A virus type, with A(H1N1)pdm09 being the main identified subtype.
- Respiratory syncytial virus (RSV) activity remains very low.
Overview
ECDC monitors respiratory illness rates and virus activity across the EU/EEA. Findings are presented in the European Respiratory Virus Surveillance Summary (ERVISS.org), which is updated weekly.
Key visualisations from the weekly bulletin are included below.
All data are provisional and may be affected by reporting delays, incomplete country data or low testing volumes. A few countries with high testing rates can disproportionately influence pooled data. Further information is available under ‘Country notes’ and ‘Additional resources’.
